Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 7.15
-0.35 (-4.67%)
Aug 1, 2025, 3:59 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 24.84 million as of August 1, 2025. Its market cap has increased by 15.16% in one year.
Market Cap
24.84M
Enterprise Value
23.71M
Revenue
2.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.15
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 24.84M, a decrease of -61.54%. That is a compound annual growth rate of -13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 24.84M | -30.23% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | 351.14M | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 172.19B |
| GSK plc | 56.39B |
| Haleon | 32.84B |
| Smith & Nephew | 10.12B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.27B |
| HUTCHMED (China) | 2.26B |
| Oxford Nanopore Technologies | 1.92B |